Figure 3
Trends in the prevalence of pfmdr1 N86-F184-D1246 haplotype prior to and after the change in treatment policy. The arrow indicates the period of anti-malarial drug policy change.
Figure 3 | Malaria Journal
Trends in the prevalence of pfmdr1 N86-F184-D1246 haplotype prior to and after the change in treatment policy. The arrow indicates the period of anti-malarial drug policy change.